Intellia Therapeutics Inc...
9.68
-0.37 (-3.68%)
At close: Jan 14, 2025, 3:59 PM
10.23
5.68%
Pre-market Jan 15, 2025, 08:53 AM EST

Intellia Therapeutics Inc. Forecast

Stock Price Forecast

The 17 analysts with 12-month price forecasts for NTLA stock have an median target of 54, with a low estimate of 12 and a high estimate of 91. The median target predicts an increase of 457.85% from the current stock price of 9.68.

Analyst Consensus: Buy
Target Low Average Median High
Price $12 $48.53 $54 $91
Change 23.97% 401.34% 457.85% 840.08%

AI Analyst Report

Oppenheimer has reaffirmed an Outperform rating on... Unlock content with Pro Subscription

Updated Jan 13, 2025

Rating Jun 24Aug 24Sep 24Oct 24Nov 24Jan 25
Strong Buy 000010
Buy 523143
Hold 000311
Sell 000000
Strong Sell 000000
Total 5 2 3 4 6 4

Financial Forecast this Year

Revenue This Year
53.93M
from 36.27M
Increased by 48.7%
Revenue Next Year
53.11M
from 53.93M
Increased by -1.5%
EPS This Year
-5.3
from -5.42
Increased by 2.2%
EPS Next Year
-5.18
from -5.3
Increased by 2.3%